PharmTech LCGC Sciex Webinar 11.10
|Articles|January 15, 2009

Chiral Technologies Europe Acquires ChromTech Ltd.

Chiral Technologies Europe (Illkirch Cedex, France), a wholly owned subsidiary of DAICEL Chemical Industries, announced the acquisition of ChromTech Ltd. (Congleton, UK).

Chiral Technologies Europe (Illkirch Cedex, France), a wholly owned subsidiary of DAICEL Chemical Industries, announced the acquisition of ChromTech Ltd. (Congleton, UK). The two companies’ combined product lines of enantioselective chromatography columns are designed for separating pharmaceutical and biopharmaceutical chiral compounds. ChromTech’s protein-based columns, which function in the reversed-phase mode with mobile phases containing low organic concentrations and having moderate pH values, will complement the DAICEL polysaccharide-based products, according to Chiral Technologies Europe President Dieter Heckmann.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.